Chronic Shoulder Pain
September 16, 2002
Results of Entropin's study of Esterom, an investigational drug for the treatment of acute shoulder pain, indicated that subjects treated with 10% Esterom showed clinical improvements. However, these results were not statistically significant when compared with subjects treated with placebo. The double-blinded placebo-controlled phase II/III trial, enrolled 173 subjects in 10 sites throughout the U.S. Each subject was treated on three consecutive days with a dosage of 10% Esterom or placebo control. Based on these results, Entropin has decided to forego further development of Esterom.